Juillerat-Jeanneret L: Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother Pharmacol 2011, 68:1161?172 [Epub ahead of print] Hou XW, Jiang Y, Wang LF, Xu HY, Lin HM, He XY, He JJ, Zhang S: Protective part of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities. Toxicol Lett 2009, 187:40?4. Hebishima T, Matsumoto Y, Watanabe G, Soma G, Kohchi C, Taya K, Hayashi Y, Hirota Y: Protective effects with the immunopotentiator from Pantoeaagglomerans 1 on chemotherapeutic agent-induced macrophage development inhibition. Anticancer Res 2010, 30:2033?040. Seligmann IC, Lima PD, Cardoso Pc, Khayat AS, Bahia MO, Buchi Dde F, Cabral IR, Burbano RR: The anticancer homeopathic composite “Canova method” isn’t genotoxic for human lymphocytes in vitro. Genet Mol Res 2003, 30:223?28. Hana G, Bar-Sela G, Zhana D, Mashiach T, Robinson E: The use of complementary and option therapies by cancer patients in northern Israel. Isr Med Assoc J 2005, 7:243?47. Han SB, Lee CW, Kang MR, Yoon YD, Kang JS, Lee KH, Yoon WK, Lee K, Park SK, Kim HM: Pectic polysaccharide isolated from Angelica gigas Nakai inhibits melanoma cell metastasis and development by straight stopping cell adhesion and activating host immune functions. Cancer Lett 2006, 243:264?73. W chli C, Baumgartner S, Bastide M: Impact of low doses and high homeopathic potencies in normal and cancerous human lymphocytes: an in vitro isopathic study. J Altern Complement Med 2006, 12:421?27. De Oliveira CC, Ana PR A, De Oliveira SM, et al: Developments on drug discovery and on new therapeutics: extremely diluted tinctures act as biological response modifiers. BMC Complement Altern Med 2011, 11:101. Sato DY, Wal R, Oliveira CC, Cattaneo RI, Malvezzi M, Gabardo J, Buchi DF: Histopathological and immunophenotyping research on typical and sarcoma 180-bearing mice treated using a Brazilian homeopathic medication. Homeopathy 2005, 94:26?2. Pascual-Carpe F, Vicente-Ortega V, Campos-Aranda M, Ya z-Gasc J: In vivo treatment of melanoma (B16F10) with a homeopathic agent and using a cytokine (IFN-). Oncol Res 2006, 16:211?16. Es S, Kuttan G, Kc P, Kuttan R: Effect of homeopathic medicines on transplanted tumors in mice. Asian Pac J Cancer Prev 2007, eight:390?94. Xie Y, Bai O, Yuan J, Chibbar R, Slattery K, Wei Y, Deng Y, Xiang J: Tumor apoptotic bodies inhibit CTL responses and antitumor immunity by means of membrane-bound transforming development factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses. Cancer Res 2009, 69:7756?766. Seligmann IC, Lima PD, Cardoso Computer, Khayat AS, Bahia MO, Buchi De F, CabralI R, Burbano RR: The anticancer homeopathic composite “Canova method” is just not genotoxic for human lymphocytes in vitro.BuyL-Homopropargylglycine Genet Mol Res 2003, 2:223?38.2408959-55-5 Price Qu P, Yan C, Du H: Matrix metalloproteinase 12 overexpression in myeloid lineage cells plays a important function in modulating myelopoiesis, immune suppression, and lung tumorigenesis.PMID:23659187 Blood 2011, 117:4476?489 [Epub ahead of print] Wang H, Xie X, Lu WG, Ye DF, Chen HZ, Li X, Cheng Q: Ovarian carcinoma cells inhibit T cell proliferation: suppression of IL-2 receptor beta and gamma expression and their JAK-STAT signaling pathway. Life Sci 2004, 74:1739?749. Wang Y, Da’Dara AA, Thomas PG, Harn DA: Dendritic cells activated by an anti-inflammatory agent induce CD4+ T helper form 2 responses without having impairing CD8+ memory and effector cytotoxic T-lymphocyte responses. Immunology 2010, 129:406?17.52.